Search results
Found 7364 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
First digital atlas of human fetal brain development published
25 October 2023
The first digital atlas showing how the human brain develops in the womb has been published by a global research team led by the University of Oxford.
Estimating hospital-acquired SARS-CoV-2 infections in England
23 October 2023
An estimated 95,000–167,000 inpatients at English National Health Service (NHS) hospitals caught SARS-CoV-2 while in hospital during England’s ‘second wave’ of COVID-19, between June 2020 and March 2021, reports a study in Nature. The findings reveal the scale of hospital transmissions and highlight contributing factors, such as a limited number of single rooms.
New AI tool could help predict viral outbreaks
19 October 2023
As the COVID-19 pandemic demonstrated, viruses can quickly evolve new ways of evading our immune systems, undermining our efforts to control outbreaks. But a new artificial intelligence (AI) tool developed by researchers at the University of Oxford and Harvard Medical School could help predict new viral variants before they emerge. The findings have been published in the journal Nature.
New translational unit launched to further critical research into multiple myeloma
19 October 2023
The Oxford Translational Myeloma Centre (OTMC) will be a collective force of research, outreach and patient care that will transform treatment opportunities for multiple myeloma cancer patients.
Radcliffe Science Library Reopened!
17 October 2023
Back in February 2020 the Radcliffe Science Library (RSL) team packed up our boxes, moved our books to the VHL and closed the doors on the RSL. This was to allow a thorough refurbishment of the building. Now more than three years later the RSL has reopened to the staff and the students of the University of Oxford.
Professor Eileen Parkes appointed to lead Oxford’s Experimental Cancer Medicine Centre
17 October 2023
Eileen Parkes, Associate Professor in Innate Tumour Immunology in the Department of Oncology, will lead the expansion of the Oxford’s Experimental Cancer Medicine Centre (ECMC) programmes in early drug development and biomarker research.
Scholarship programme for the innovators of the future launched
13 October 2023
The Ellison Scholars programme, announced by the Ellison Institute of Technology (EIT), will find and fund students and train them to become leaders with the skills to invent, improve, and manage the next generation of technology, to help solve some of humanity’s most challenging and enduring problems.
Tackling persistent inequities underlying maternal mortality
12 October 2023
The Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK) collaboration, co-led by Nuffield Department of Population Health’s National Perinatal Epidemiology Unit, has published the full Saving Lives, Improving Mothers’ Care report on women who died during, or up to a year after, pregnancy between 2019 and 2021.
Palestinian medical students visit Oxford for MedEd summer school
11 October 2023
In July and August, twenty medical students from the Arab American University of Palestine (AAUP), based in Jenin, visited Oxford for two weeks to learn clinical skills and observe OUH clinicians.
Tackling mental illness by supporting industry to develop new drugs
11 October 2023
An academic/industry partnership, based at the NIHR Oxford Health Biomedical Research Centre, is helping companies use experimental medicine approaches to speed up development of new drugs to treat psychiatric disorders.
The Big Shot. Oxford, Africa and the R21 malaria vaccine
11 October 2023
What we desperately need are new tools to improve malaria control, and this is the first vaccine that can be deployed at scale, that will be affordable, and can be used widely in Africa on a scale of hundreds of millions of doses each year.
Oxford to lead global collaboration to research and develop next-generation COVID-19 and flu vaccines
11 October 2023
Project headed by Oxford University’s Professor Teresa Lambe OBE (Calleva Head of Vaccinology and Immunology, Department of Paediatrics) and co-developer of the Oxford/AstraZeneca COVID-19 vaccine and Paul Klenerman (Sidney Truelove Professor, Nuffield Department of Medicine)
‘We could eradicate malaria by 2040’ says expert after revolutionary vaccine is approved by WHO
11 October 2023
The World Health Organization has approved a new vaccine that scientists argue will be a game-changer in the fight against malaria, which kills half a million people in Africa every year. Trials have shown that the R21/Matrix vaccine, developed by Oxford University together with the Serum Institute of India, reduces malaria by up to 75%. It can be manufactured cheaply and on a mass scale. The Conversation Weekly spoke to chief investigator Adrian Hill, who is also director of the Jenner Institute at the University of Oxford, about this revolutionary vaccine. Below are edited excerpts from the podcast.
Wearable sensors provide early detection of progression in Parkinson’s Disease
11 October 2023
A team of researchers from the University of Oxford has shown for the first time that it is possible to track the progression of Parkinson’s Disease accurately using specially trained machine learning algorithms to analyse data derived from sensor devices worn by patients.
Professor Alan Bernstein appointed as new University of Oxford Director of Global Health
10 October 2023
Professor Alan Bernstein has been appointed as the new head of Oxford Global Health, which will bring together and showcase the breadth of global health research across the University of Oxford.
New research finds that reducing antibiotic usage in animal feed is not enough to combat antibiotic resistance
6 October 2023
A new study led by the University of Oxford has found that natural evolution of antibiotic resistance genes has maintained resistance in bacteria despite a reduction in the use of antibiotics. The findings demonstrate the importance of understanding the regulatory evolution of resistance genes to strategically combat AMR. The study has been published in the Journal of the International Society for Microbial Ecology (ISME).
Gene therapy opens new possibilities for treating chronic pain
6 October 2023
Researchers from the Nuffield Department of Clinical Neurosciences at the University of Oxford, along with colleagues at Cambridge University and Barts and the London School of Medicine and Dentistry, have shown the potential of a new gene therapy approach to silence human sensory neurons (nerve cells) as a means of treating persistent pain. Many current drugs for chronic pain are highly addictive, which makes it important to discover new alternatives.
Examination Marshal Recruitment
6 October 2023
New Governance, Risk & Compliance Hub is live
5 October 2023
UNIQ+ Postgraduate Research Internships 2024 - Project requests
5 October 2023
The UNIQ+ Postgraduate Research Internships programme is seeking project requests from research staff who are willing to supervise interns working in their department during the 2024 summer vacation.